Search

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

This bimonthly update provides data submitted to CARAlert for the reporting period 1 May to 30 June 2024. These data can be used to support the prevention and control of antimicrobial resistance.

This bimonthly update provides data submitted to CARAlert for the reporting period 1 March to 30 April 2024. These data can be used to support the prevention and control of antimicrobial resistance.

This bimonthly update provides data submitted to CARAlert for the reporting period 1 January to 29 February 2024. These data can be used to support the prevention and control of antimicrobial resistance.

Bimonthly data update 30 provides data submitted to CARAlert for the reporting period 1 September 2022 to 31 October 2022. This data is able to be used to inform, and support, the prevention and containment of antimicrobial resistance.

The Bimonthly Data Update 27 provides data submitted to National Alert System for Critical Antimicrobial Resistances (CARAlert) for the reporting period 1 March 2022 to 30 April 2022. This data is able to be used to inform strategies to prevent and contain antimicrobial resistance (AMR).

Update 23 provides data submitted to CARAlert for the reporting period 1 May 2021 to 30 June 2021to support prevention and containment of antimicrobial resistance.

This brochure provides information for consumers regarding infections for which antibiotics may not be appropriate, and the role of antibiotics in the development of antimicrobial resistance.

This latest CARAlert Data Update includes data submitted to CARAlert between 1 March 2021 and 30 April 2021. This update provides useful information to support prevention and containment of antimicrobial resistance.

A joint statement from the Council of Presidents of Medical Colleges (CPMC) and the Commission has been made regarding the importance of responding to the long-term lack of improvement in compliance with antimicrobial prescribing guidelines in Australia.

This report provides analyses of data on confirmed critical antimicrobial resistances (CARs) submitted to the National Alert System for Critical Antimicrobial Resistances (CARAlert) for 2019, and trend data for 2017 to 2019.

The National Alert System for Critical Antimicrobial Resistances (CARAlert) collects data on nationally agreed priority organisms with critical resistance to last-line antimicrobial agents.

This Standard Operating Procedure provides instructions for APAS contributors on how to use the Statistical Area (SA) Geoanalytics Dashboard. The dashboard offers detailed antimicrobial resistance data by location using the Australian Statistical Geography Standard (ASGS) for de-identified, location-based analysis.

This quarterly update includes data submitted to CARAlert for the reporting period 1 July to 30 September 2024. These data support the prevention and control of critical antimicrobial resistances.

This issue includes items on antimicrobial resistance, digital health, oral health, sustainability, clinical deterioration, leadership and culture, infection prevention and control, COVID-19, and more. Also covered are the latest from BMJ Quality & Safety, Journal of Patient Safety, International Journal for Quality in Health Care, and The Joint Commission Journal on Quality and Patient Safety.

This report provides analyses of data captured by Australian Passive AMR Surveillance (APAS) on antimicrobial resistance trends in multidrug-resistant organisms (MROs) from 2006 to 2023. The MROs included are:

• Vancomycin resistance in Enterococcus faecium (VRE)
• Fluoroquinolone resistance in Escherichia coli
• Methicillin resistance in Staphylococcus aureus (MRSA).

Released July 2024

This issue includes items on antimicrobial resistance, patient safety, partnering with consumers, healthcare worker well-being, opioids, falls, leadership, COVID-19 and more.

Also covered are the latest issues of Australian Prescriber and The Joint Commission Journal on Quality & Patient Safety along with early online papers from BMJ Quality & Safety.

This issue includes items on antimicrobial shortages, hospital care, medication safety, medication reconciliation, digital health workforce, surgery, guidelines, COIVD-19 and more.

Also covered are the latest issue of BMJ Quality & Safety and early online papers from BMJ Quality & Safety along with the latest from the UK’s NICE.

Bimonthly data update 29 provides data submitted to CARAlert for the reporting period 1 July 2022 to 31 August 2022. This data is able to be used to inform, and support, the prevention and containment of antimicrobial resistance.